A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
Identifiers
Identifiers
Services
Services
Date issued
2011Journal title
INVESTIGATIONAL NEW DRUGS
Type of content
Artigo
